for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

U.S. FDA approves Johnson & Johnson's MS treatment

March 19 (Reuters) - The U.S. Food and Drug Administration has approved Johnson & Johnson’s multiple sclerosis (MS) treatment, Ponvory, the company said on Friday.

The approval was granted to the U.S. drugmaker’s subsidiary Janssen Pharmaceutical Companies. (Reporting by Mrinalika Roy in Bengaluru; Editing by Shailesh Kuber)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up